Welcome from the Chair
10th IJERPH Webinar
Clinical Consequences of Gut Microbiota Dysbiosis: Exploring New Associations
Gut microbiota play a central role in the pathophysiology of the diseases in the gastrointestinal tract and beyond GI tract. Many chronic diseases originate from distorted gut microbiota composition (dysbiosis). The main function of gut microbiota includes regulation of host physiology (regulation of immune system, protection of intestinal barrier, regulation of gut motility and participation in the digestion of food), diverse metabolic functions and regulation of gut-brain barrier. The communication between the gut microbiota and their diverse metabolites and human body systems regulates physiological aspects of health and disease.
COVID-19 infection leads to profound alterations in gut microbiome and affects the gut brain axis leading to irritable bowel syndrome. A number of trials using gut microbiota modulating therapy such as dietary modifications, prebiotics, probiotics and fecal microbiota transplantation (FMT) has already been initiated.
The webinar focuses on the recent development in the understanding of the gut microbial dysbiosis in COVID-19 infection and the pathogenesis of COVID-19 associated irritable bowel syndrome. Further important topic are recent advancements in the pathophysiology and treatment of histamine intolerance. Finally, we will present the new developments in the diagnosing irritable bowel syndrome and other food intolerances.
Date: 12 January 2023
Time: 4:00 pm CET | 10:00 am EST | 11:00 pm CST Asia
Webinar ID: 814 7101 6732
Webinar Secretariat: email@example.com
Teaching Hospital of the University of Jena, Thuringia-Clinic Saalfeld, Saalfeld, Germany
Professor of Internal Medicine and Gastroenterology at the University Erlangen-Nuremberg in Germany. Head of the Department of Internal Medicine (Gastroenterology, Endocrinology and Infectiology) at the Thuringia Clinic Saalfeld, Teaching Hospital of the University of Jena since 2010. Fellow of the American Association of Gastroenterology (AGAF) and member German Association of Gastroenterology and German Association of Internal Medicine (DGIM). Research focus: role of microbiota in gastrointestinal and extraintestinal diseases, fecal microbiota transplantation, endoscopic diagnostic and treatment of irritable bowel syndrome, irritable bowel syndrome and food allergy. More than 300 original peer-reviewed publications, more than 15 book chapters.
Hector Center of Excellence for Nutrition, Exercise and Sports, University of Erlangen-Nürnberg, Erlangen, Germany
Prof. Yurdagül Zopf is Professor for Clinical and Experimental Nutritional Medicine, gastroenterologist, and specialist in nutritional medicine. Since 2017, she is head of the Hector-Center for Nutrition, Exercise, and Sports and heads the nutrition team of the First Department of Medicine since 2010. Her research interests are celiac disease, cancer cachexia syndrome, inflammatory bowel disease, food intolerances and allergies, and microbiome and immunopathogenesis.
First Department of Medicine, University Erlangen-Nuremberg, Erlangen, Germany
Prof. Timo Rath is Professor for Gastroenterology at the First Department of Internal Medicine, University Erlangen-Nuremberg. He is the Head of the Functional GI Disorder Unit. His clinical and scientifical work is focused on new and emerging endoscopic technologies such as confocal endomicroscopy or artificial intelligence in endoscopy. He is author of more than 100 publications.
Time in CET
Prof. Dr. Peter Konturek
4:00 - 4:10 pm
Prof. Dr. Peter Konturek
Alterations of Gut Microbiome in COVID-19 Infection
4:10 - 4:30 pm
Prof. Dr. Yurdagül Zopf
Histamine Intolerance: Myth and Facts. An Update.
4:30 - 4:50 pm
Prof. Dr. Timo Rath
The Use of Confocal Laser Endomicroscopy (CLE) In Diagnosing of Irritable Bowel Syndrome
4:50 - 5:10 pm
5:10 - 5:25 pm
Closing of Webinar
5:25 - 5:30 pm
The Gut Microbiota and Human Health
Guest Editor: Prof. Dr. Peter C. Konturek
Deadline for manuscript submissions: 31 May 2023